Barrett Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-148
| Closed | -$11K | – | 318 |
|
|
2021
Q4 | $11K | Buy |
148
+48
| +48% | +$3.31K | ﹤0.01% | 522 |
|
|
2021
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 436 |
|
|
2021
Q2 | $7K | Sell |
100
-246
| -71% | -$16.4K | ﹤0.01% | 414 |
|
|
2021
Q1 | $22K | Sell |
346
-87
| -20% | -$5.61K | ﹤0.01% | 353 |
|
|
2020
Q4 | $25K | Buy |
433
+333
| +333% | +$20.1K | ﹤0.01% | 311 |
|
|
2020
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 347 |
|
|
2020
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 345 |
|
|
2020
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 311 |
|
|
2019
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 343 |
|
|
2019
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 326 |
|
|
2019
Q2 | $7K | Sell |
100
-33
| -25% | -$2.17K | ﹤0.01% | 322 |
|
|
2019
Q1 | $9K | Buy |
133
+33
| +33% | +$2.19K | ﹤0.01% | 323 |
|
|
2018
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 332 |
|
|
2018
Q3 | $8K | Sell |
100
-1,294
| -93% | -$97.7K | ﹤0.01% | 332 |
|
|
2018
Q2 | $99K | Hold |
1,394
| – | – | 0.01% | 196 |
|
|
2018
Q1 | $105K | Hold |
1,394
| – | – | 0.01% | 195 |
|
|
2017
Q4 | $100K | Buy |
1,394
+394
| +39% | +$29.9K | 0.01% | 205 |
|
|
2017
Q3 | $81K | Buy |
1,000
+900
| +900% | +$68.8K | 0.01% | 202 |
|
|
2017
Q2 | $7K | Hold |
100
| – | – | ﹤0.01% | 343 |
|
|
2017
Q1 | $7K | Sell |
100
-182,150
| -100% | -$12.8M | ﹤0.01% | 334 |
|
|
2016
Q4 | $13.1M | Sell |
182,250
-26,292
| -13% | -$1.95M | 1.08% | 37 |
|
|
2016
Q3 | $16.5M | Sell |
208,542
-5,456
| -3% | -$443K | 1.39% | 28 |
|
|
2016
Q2 | $17.9M | Buy |
213,998
+4,835
| +2% | +$429K | 1.54% | 27 |
|
|
2016
Q1 | $19.2M | Buy |
209,163
+2,978
| +1% | +$269K | 1.65% | 25 |
|
|
2015
Q4 | $20.9M | Sell |
206,185
-410
| -0.2% | -$42.7K | 1.82% | 22 |
|
|
2015
Q3 | $20.3M | Buy |
206,595
+1,133
| +0.6% | +$126K | 1.85% | 19 |
|
|
2015
Q2 | $24.1M | Buy |
205,462
+2,112
| +1% | +$231K | 1.98% | 17 |
|
|
2015
Q1 | $20M | Buy |
203,350
+12,178
| +6% | +$1.24M | 1.65% | 23 |
|
|
2014
Q4 | $18M | Buy |
191,172
+11,385
| +6% | +$1.18M | 1.41% | 30 |
|
|
2014
Q3 | $19.1M | Buy |
179,787
+2,725
| +2% | +$267K | 1.55% | 24 |
|
|
2014
Q2 | $14.7M | Buy |
177,062
+99,208
| +127% | +$7.72M | 1.2% | 35 |
|
|
2014
Q1 | $5.52M | Buy |
77,854
+68,956
| +775% | +$5.41M | 0.48% | 59 |
|
|
2013
Q4 | $668K | Buy |
8,898
+4,906
| +123% | +$342K | 0.06% | 107 |
|
|
2013
Q3 | $251K | Hold |
3,992
| – | – | 0.02% | 142 |
|
|
2013
Q2 | $205K | Buy |
+3,992
| New | +$208K | 0.02% | 147 |
|
Other funds holding GILD
Barrett Asset Management's GILD Position: Q1 2022 in Review
Barrett Asset Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 148 shares — an estimated $11K sold.
Barrett Asset Management first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $24.1M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Barrett Asset Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Barrett Asset Management sold 148 Gilead Sciences shares in Q1 2022, an estimated $11K.
- Barrett Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- Barrett Asset Management's Gilead Sciences position peaked at $24.1M in Q2 2015.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.